Contract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share and Outlook - 2024 Edition
Summary
This expert trend report is a comprehensive look at the pharmaceutical finished dose contract manufacturing landscape in 2024, including analysis of dose CMO M&A activity, market size and share. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.
Scope
This 65-page report gives an important expert quantitative analysis on the pharmaceutical commercial contract dose manufacturing industry. Findings are based on the industry’s most comprehensive database of the dose CMO industry (GlobalData's Contract Service Providers Database). This analysis is driven by a proprietary model of the dose manufacturing industry, which is continuously updated and refined. The 8 tables and 20 figures throughout the report illustrate major points and trends. This report is required reading for -
- CMO executives and strategic decision-makers: to improve understanding of the dose CMO industry and provide a critical input for strategic planning efforts.
- Sourcing and procurement executives in bio/pharmaceutical companies: to improve understanding of crucial components of the supply base that will provide insights for supplier selection and management.
- Private equity investors: they can gain a deeper understanding of the dose CMO market and important insights for identifying potential investment targets.
This report will enable the user to answer the following questions -
- What is the geographic reach of commercial dose CMOs?
- What revenues did the commercial contract dose manufacturing industry generate in the last year?
- What are the components of revenue change for contract dose manufacturers?
- What is the breakdown of 2023 revenues by different dosage forms?
- What are the characteristics of the largest dose CMOs?
- How did the revenue growth of Contract Dose manufacturers in 2023 compare to Contract API manufacturers?
- What is the outlook for the dose CMO industry?
- What is the outlook for GLP-1 receptor agonist products?
- About GlobalData
- Table of Contents
- Executive Summary
- Players
- Trends
- Industry Analysis
- Definition of the dose CMO universe
- Industry demographics
- Global versus regional reach
- Spotlight on injectables
- Major developments affecting industry structure
- Dose facility acquisitions
- Dose company acquisitions
- PE acquisitions
- Industry Size and Growth
- Growth threats and drivers
- Growth by dose form
- CMO Market Shares
- Characteristics of the largest CMOs
- GLP-1 Receptor Agonist Sales Forecast
- Analyzing Recent Dose CMO Performance
- GLP-1 Receptor Agonist Effect
- Service-specific growth
- Cell and gene therapy
- Sponsor-CMO relationships
- What it means
- Value Chain
- Companies
- Appendix
- Methodology
- Methodology for market size and growth estimates
- Deal years
- CMO classifications
- Bibliography
- Primary research - key opinion leaders
- Further reading
- About the Authors
- Contact Us
- List of Tables
- Table 1: Dose CMO trends, 2023
- Table 2: CMO acquisitions of dose manufacturing facilities, 2023
- Table 3: Summary of CMO facility acquisition of dose facilities activity, 2013-22
- Table 4: Dedicated CMO acquisitions of companies with commercial dose capabilities, 2023
- Table 5: PE investments in the dose CMO industry, 2013-23
- Table 6: Dose revenue composition and capabilities of leading CMOs, 2023
- Table 7: Geographical reach of dose CMO universe, 2023
- Table 8: Further reading
- List of Figures
- Figure 1: Leading dose CMOs, 2023
- Figure 2: Top contract dose trends in the CMO industry, 2023
- Figure 3: Geographic reach of the dose CMO universe, 2023
- Figure 4: Geographic distribution of commercial dose facilities, 2023
- Figure 5: Geographic distribution of commercial dose injectable facilities, 2023
- Figure 6: Dose CMO revenue, 2013-23
- Figure 7: Components of growth for dose CMOs, 2022-23
- Figure 8: Dose CMO dosage form revenue segments in 2023 ($B)
- Figure 9: Dose CMO dosage form revenue segments percentage change from 2022-23 (%)
- Figure 10: CMO count by dose revenue tiers, 2023
- Figure 11: Dose CMO industry market share by company revenue tier, 2023
- Figure 12: Dose CMO industry market share by company revenue tier, percentage change from 2022-23 (%)
- Figure 13: Revenue growth for public CMOs
- Figure 14: Marketed GLP-1 receptor agonist sales forecasts, 2023-27
- Figure 15: Pipeline GLP-1 receptor agonist sales forecasts, 2023-27
- Figure 16: CMO services sector performance, 2023
- Figure 17: GLP-1 receptor agonists’ contract manufacturing agreements
- Figure 18: Dose outsourcing of FDA NME approvals by sponsor market cap
- Figure 19: NME dose outsourcing contracts, by sponsor market cap, 2014-23
- Figure 20: The contract manufacturing value chain
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook